Literature DB >> 19712589

SH2D4A regulates cell proliferation via the ERalpha/PLC-gamma/PKC pathway.

Tingting Li1, Wei Li, Jingyu Lu, Hong Liu, Yinghui Li, Yanyan Zhao.   

Abstract

SH2D4A, comprising a single SH2 domain, is a novel protein of the SH2 signaling protein family. We have previously demonstrated SH2D4A is expressed ubiquitously in various tissues and is located in the cytoplasm. In this study we investigated the function of SH2D4A in human embryonic kidney (HEK) 293 cells using interaction analysis, cell proliferation assays, and kinase activity detection. SH2D4A was found to directly bind to estrogen receptor alpha (ERalpha), and prevent the recruitment of phospholipase C-gamma (PLC-gamma) to ERalpha. Moreover, we observed its inhibitory effects on estrogen-induced cell proliferation, involving the protein kinase C (PKC) signaling pathway. Together, these findings suggested that SH2D4A inhibited cell proliferation by suppression of the ERalpha/PLC-gamma/PKC signaling pathway. SH2D4A may be useful for the development of a new anti-cancer drug acting as an ER signaling modulator.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712589     DOI: 10.5483/bmbrep.2009.42.8.516

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  4 in total

1.  Estrogen receptor α inhibitor activates the unfolded protein response, blocks protein synthesis, and induces tumor regression.

Authors:  Neal D Andruska; Xiaobin Zheng; Xujuan Yang; Chengjian Mao; Mathew M Cherian; Lily Mahapatra; William G Helferich; David J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

2.  Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.

Authors:  Carolin Ploeger; Nina Waldburger; Angelika Fraas; Benjamin Goeppert; Stefan Pusch; Kai Breuhahn; Xin Wei Wang; Peter Schirmacher; Stephanie Roessler
Journal:  Hepatology       Date:  2016-07-15       Impact factor: 17.425

3.  A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma.

Authors:  Priscila H Goncalves; Lance K Heilbrun; Michael T Barrett; Shivaani Kummar; Aaron R Hansen; Lillian L Siu; Richard L Piekarz; Ammar W Sukari; Joseph Chao; Mary Jo Pilat; Daryn W Smith; Lindsay Casetta; Scott A Boerner; Alice Chen; Elizabeth Lenkiewicz; Smriti Malasi; Patricia M LoRusso
Journal:  Oncotarget       Date:  2017-05-16

4.  Functional genetic diversity in an exploited marine species and its relevance to fisheries management.

Authors:  Eleni L Petrou; Angela P Fuentes-Pardo; Luke A Rogers; Melissa Orobko; Carolyn Tarpey; Isadora Jiménez-Hidalgo; Madonna L Moss; Dongya Yang; Tony J Pitcher; Todd Sandell; Dayv Lowry; Daniel E Ruzzante; Lorenz Hauser
Journal:  Proc Biol Sci       Date:  2021-02-24       Impact factor: 5.349

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.